Eli Lilly

$144.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-0.10%) Today
-$0.01 (-0.01%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Eli Lilly and other stocks, options, and ETFs commission-free!

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN. The listed name for LLY is Eli Lilly & Co.

CEO
David A. Ricks
Employees
33,625
Headquarters
Indianapolis, Indiana
Founded
1876
Market Cap
138.47B
Price-Earnings Ratio
23.72
Dividend Yield
1.98
Average Volume
3.78M
High Today
$145.34
Low Today
$142.61
Open Price
$145.06
Volume
3.22M
52 Week High
$170.75
52 Week Low
$115.92

Collections

LLY News

ReutersNov 24

Eli Lilly to supply 26,000 doses of COVID-19 antibody drug to Canada

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters)
BenzingaNov 24

Lilly and the Government of Canada sign an agreement for the supply of bamlanivimab to treat COVID-19 in Canada

Bamlanivimab is a SARS-CoV-2-neutralizing antibody that emerged from the collaboration between Lilly and Vancouver-based AbCellera TORONTO, Nov. 24, 2020 /CNW/
New York TimesNov 22

Covid-19: Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval

Covid-19: Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval Ben Carson, the housing and urban development secretary, is the latest in a long line of

LLY Earnings

$0.00
$0.63
$1.26
$1.89
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Available Jan 29, Pre-Market

You May Also Like

More LLY News

ReutersNov 20

Canada grants interim authorization to Eli Lilly's COVID-19 antibody drug

FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker, in Fegersheim near Strasbourg, France,
CNBCNov 20

Eli Lilly CEO on WHO advising against using remdesivir to treat Covid-19

Eli Lilly CEO on WHO advising against using remdesivir to treat Covid-19 The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Li
BenzingaNov 20

Eli Lilly's Arthritis Drug Gets Emergency Use Approval For Treatment Of COVID-19

Eli Lilly And Co’s (NYSE: LLY) rheumatoid arthritis drug baricitinib has been issued an emergency use authorization, in combination with Gilead Sciences, Inc’s